Treatment options are limited, and supporting evidence generally is poor.
Sponsoring Organizations: Infectious Diseases Society of America and American Society of Tropical Medicine and HygieneTarget Audience: Internists, pediatricians, family practitioners, primary care physicians, dermatologists, and infectious disease and tropical medicine clinicians practicing in the U.S. and Canada
Target Population: Any patients with a history of exposure in leishmaniasis-endemic regions and skin lesions or systemic findings that suggest or have been diagnosed as cutaneous, mucocutaneous, or visceral leishmaniasis
Background and Objective
These guidelines describe the diagnosis and management of patients with suspected leishmaniasis. Guideline development included systematic grading of quality of evidence and strength of the re…
Reviewing Author
DisclosuresConsultant/Advisory BoardOneHealthTrust (formerly Center for Disease Dynamics, Economics, and Policy); Global Health Institute, University of Wisconsin
RoyaltiesUpToDate
Editorial BoardsJournal of Travel Medicine
DisclosuresConsultant/Advisory BoardOneHealthTrust (formerly Center for Disease Dynamics, Economics, and Policy); Global Health Institute, University of Wisconsin
RoyaltiesUpToDate
Editorial BoardsJournal of Travel Medicine